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Abstract
Medical decision-making is moving away from
the traditional one-off dyadic encounter between the
patient and physician, and transitioning towards a
more inclusive, shared decision-making process that
also considers the inputs from other stakeholders. This
ensures that a patient’s decision is not only based
on a medical opinion, but also includes other
considerations such as impact on family members,
legal and financial implications, and experiences of
patients in similar situations. However, given the
sensitive nature of health data and decisions, there
are several challenges associated with safeguarding
the privacy, security and consent of all contributors
and assuring the integrity of the process. We propose
a collaborative medical decision-making platform that
uses a consensus building mechanism implemented
using Blockchain-based Smart Contracts to address
some of the above challenges, thereby giving the
participants confidence that both the decision-making
process and the outcome(s) can be trusted. We
also present a proof-of-concept implementation using
the private Ethereum Blockchain to demonstrate
practicability.
1. Introduction
Shared decision-making (SDM) is considered the
pinnacle of patient-centered care since it involves active
patient engagement in making healthcare decisions that
affect them directly [1]. Research has traditionally
conceptualised SDM as a one-off dyadic encounter
between the patient and physician within the confines of
the consultation room. However, SDM is increasingly
recognised as a collaborative process that involves
not only the patient and physician but also other
stakeholders, including family members, friends, carers,
multi-disciplinary medical teams, fellow patients, social
workers, and legal representatives [2]. The preferences
and values of this diverse group of participants can be
influenced by a range of different cultural, financial,
ethical, legal, spiritual, and other determinants, and in
turn shape the decision that is presented to the patient.
Consider the scenario of an early stage breast cancer
patient who needs to choose between mastectomy and
lumpectomy with radiation [3]. Although the patient
maintains final decisional authority to accept or reject
any medical intervention, she may seek input and
guidance from the lead clinician, surgeon, radiation
oncologist, medical oncologist, family member(s),
well-wisher(s), and other fellow patient(s). However,
she may not be willing to share her health data and
personal preferences and values with all of them. For
instance, she may not want to share her health data
with certain family members, or her spiritual and
cultural values with the lead clinician. Family members
may not want to reveal their preferences for the
different treatment options to the patient or to other
family members. The members of the multi-disciplinary
medical team may want to discuss their professional
opinions with each other and reach a resolution before
sharing their unified recommendation with the patient
or the family members. Fellow patients may be willing
to share their personal experiences only under the
condition of anonymity.
Given the complexity of the SDM process and
human perception and behaviour, it is unlikely that
an agreement that considers the patient’s personal
preferences, healthcare providers’ recommendations,
and family members’ wishes can be reached in a single
clinical encounter. This necessitates a collaborative
process that is considered reliable and trustworthy by
all participants, protects sensitive information at all
times, enables traceability and auditability to maintain
accountability, and supports distributed, iterative, and
patient-centered deliberation, extending beyond the
traditional boundaries of SDM [4].
To address these challenges we propose a novel
platform for collaborative medical decision-making
(CMDM) that enables participants to collaboratively
develop and agree on medical decisions that are





in the best interest of the patient. In a shift from
traditional face-to-face consultations, our proposed
approach, which leverages Blockchain-based Smart
Contract technology, supports asynchronous digital
deliberation via pseudo-anonymous participation,
empowering all participants to honestly share their
opinions and influence the final decision. The use
of Blockchain technology helps address some key
concerns such as security, privacy, transparency,
immutability, traceability and auditability. We
demonstrate the practicability of the proposed system
by implementing a proof-of-concept using the private
Ethereum Blockchain. To the best of our knowledge,
our proposal is the first to use a Smart Contract-based
consensus reaching process for patient-centred medical
decision-making.
The paper proceeds as follows. Section 2 presents
related work on medical decision-making, consensus
building, and Blockchain and Smart Contracts
application in healthcare. Section 3 details the problem
addressed in this research work while Section 4 presents
our proposed solution, including a proof-of-concept
implementation. Section 5 concludes the paper.
2. Background and Related Work
This section presents an overview of medical
decision-making models, consensus building, and
blockchain technology.
2.1. Medical Decision-Making
The research literature has traditionally considered
medical decision-making to be a dyadic encounter
between patient and physician [5] involving three types
of decision-making models. In the paternalistic model,
the physician is solely responsible for the medical
decision, while the patient’s participation is restricted
to providing consent for the treatment. Conversely,
in the informed model, the patient deliberates on the
medical decision, while the physician’s role is limited
to that of providing expertise and information. In
contrast, in SDM the physician shares information about
the patient’s condition and the treatment alternatives
while the patient shares preferences over the different
treatment alternatives, and both parties take appropriate
steps to jointly reach agreement on the preferred
treatment option. With the growing technologisation of
healthcare and the increasing digitisation of knowledge,
medical decision-making has also been considered a
triadic consultation involving the computer as a third
influential part [6]. There is growing consensus that
medical decision-making can no longer be dyadic
(or triadic) and one-off, but must involve multiple
stakeholders [7]. To the best of our knowledge, our
proposed CMDM platform based on iterative consensus
building is the first of its kind that extends medical
decision-making beyond the traditional SDM to a truly
patient-centred collaborative process.
2.2. Consensus Building
Group decision-making (GDM) is a crucial activity
of human life in which multiple participants, with
individual opinions and preferences, attempt to make a
collective decision regarding a specific real-life problem
or situation [8]. However, those individual opinions
and preferences may differ substantially, and therefore,
the decision(s) resulting from their fusion might not
be acceptable to all participants. A consensus building
mechanism may increase the agreement level within
the group prior to proceeding to the selection phase,
i.e., the last step in the decision-making process, in
which a selection criterion is applied to determine the
group’s final decision(s) [9]. Consensus building is a
popular approach in the field of economics and decision
science [10] that has been applied in a diverse range of
application domains such as public policy [11], smart
cities [12], renewable energy [13], and education [14].
As far as we know, limited research has been done on
using consensus building for SDM. Enabling consensual
and collectively accepted decisions is paramount to
ensure that patients receive the best medical options that
not only reflect their personal preferences and values
but also their doctors’ recommendations and families’
wishes. Although a number of studies have suggested
the use of generic multi-criteria decision-making
techniques and/or a GDM model to help patients,
physicians, and their families select a medical treatment
among a set of available options [15, 16, 17], these
proposals limit the decision-making process to a single
round of discussion and do not guarantee that all
participants’ preferences are considered. In contrast,
our proposal supports multi-party, iterative consensus
building and also considers additional participant,
process, and information-centric requirements as
outlined in Section 3 and 4.
2.3. Blockchain and Smart Contracts
A Blockchain is an immutable, distributed
ledger for recording digital transactions that are
secured by cryptographic techniques and managed
by a decentralized community over a peer-to-peer
network [18]. Blockchain technology has a number of
inherent properties that address some of the challenges
of SDM including security, privacy, transparency,
immutability, traceability and auditability [4]. Using
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Blockchain, complex interactions between multiple
stakeholders can be documented and tracked through
a time-stamped workflow. Additionally, Blockchain
supports the use of pseudo-identities to retain the
anonymity of participants. Smart Contracts are
deterministic, immutable computer programs that are
deployed and executed on the Blockchain [19]. Once
deployed, they cannot be changed – the only way
to modify a Smart Contract is to deploy a new
instance. Therefore, Smart Contracts are protected
from deletion, tampering and revision. They can be
developed and run as decentralized apps that interact
with the Blockchain and facilitate on-chain storage.
There are several proposals in the literature
on Blockchain-based healthcare applications
including health data sharing [20], patient health
records [21], clinical trials [22], and wearable data
marketplace [23]. To the best of our knowledge,
there is only one previous research work that uses
Blockchain technology for CMDM using the notion of
Proof-of-Familiarity [24]. However, it limits the clinical
encounter to a single round making it impractical in a
real-world setting.
3. Problem Statement
Consensus building to identify the best possible
medical intervention for the patient may not be possible
in a face-to-face setting due to several reasons. The
group decision might be unduly influenced and biased
by more dominant individuals or subgroups; participants
may refuse to honestly share their preferences, values
and opinions with the group; and the face-to-face
discussion may limit patients’ ability to make decisions
based on shared inputs. In this section, we first provide
an overview of a consensus reaching process for CMDM
following by a discussion of the key participant, process
and information-centric requirements associated with
consensus building for CMDM.
3.1. Framework
The key elements of the proposed consensus
reaching process are described as follows.
• T = {t1, t2, . . . , tm} denotes a finite set of m(≥ 2)
treatment options available to the patient, e.g., t1:
mastectomy and t2: lumpectomy (with radiation).
• C = {c1, c2, . . . , cn} denotes a finite set of n(≥ 2)
criteria that are considered in the evaluation of the
treatment options, e.g., c1: effectiveness, c2: side
effects, c3: survival rate, c4: invasiveness, c5:
recovery time, and c6: related costs.
• P = {p1, p2, . . . , po} denotes a group of o(≥ 2)
participants, e.g., p1: patient, p2: partner, p3: lead
clinician, p4: multi-disciplinary cancer team, p5:
fellow patients, and p6: insurance company1.
• Λ(r) = (λ1(r), λ2(r), . . . , λo(r))T denotes a weight
vector representing the influence of all participants
in a given consensus round r, such that λk(r) is
the influence of participant pk ∈ P and ∀pk ∈
P, 0 ≤ λk(r) ≤ 1 and
∑o
k=1 λk = 1,
e.g., Λ(1) = (0.5, 0.05, 0.2, 0.2, 0.025, 0.025)T is
the initial weight vector assigned to the group of
participants P in which the patient is given higher
weight (influence) in comparison to the rest of the
participants.
• Each participant pk ∈ P provides his/her opinion over
T × C in a given consensus round r by means of an














where each assessment dmijk(r) indicates the degree
to which the ith treatment option satisfies the jth
criterion according to the kth participant in a given
consensus round r. It can be expressed using an
appropriate information domain – numerical values or
linguistic terms – and a specific preference structure
such as intervals, n-tuple or fuzzy sets.
• Figure 1 shows the automated consensus builder that
replaces the human mediator by following the general
scheme of a consensus reaching process [9]. Firstly,
individual preferences of the participants are
combined using an appropriate aggregation operator
and the current consensus degree, i.e., level of
agreement within the group, CDc(r) is computed
using a predefined consensus measure. The consensus
degree is then compared with a preset minimum
consensus threshold. If the consensus degree
exceeds the threshold (CDc(r) > threshold), the
group moves on to the selection phase; otherwise,
the consensus builder takes appropriate steps to
increase the level of agreement in the following
consensus round. This can be done in different
ways including through an interactive feedback
process [13] and automatic adjustment of the
participants’ preferences [25]. Consensus must be
achieved before a maximum predefined number
of iterations rmax is surpassed, i.e., the process
continues until CDc(r) ≥ threshold or r > rmax.
1For simplicity, we represent the multi-disciplinary cancer team
and the group of former breast cancer patients as single entities.
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Figure 1. Automated consensus builder.
3.2. Process Initiation and Participation
This section describes how the CMDM process
may be initiated by select participants, and how the
remaining participants engage by invitation only.
• As the main stakeholder, the patient (p1) may initiate
the process to discuss the different treatment options
(t1 and t2) with the group P or to seek a second/third
opinion on her condition and available/recommended
treatment options. In both scenarios, the patient may
either participate directly in the CMDM process and
ensure that her preferences are considered in reaching
consensus, or wait for the final outcome of the process
and make an informed decision after reviewing the
group’s recommendation on t1 and t2.
• The partner (p2) (family member/s or legal
representative) may initiate the process on behalf
of the patient if she is legally, physically, and/or
mentally incapable of making her own decisions, or if
explicitly asked by the patient to help reach a decision
by collaborating with the other stakeholders. In either
case, they have two options available to them – either
directly participate in the CMDM process or wait for
the final group recommendation.
• The lead clinician (p3) or the multi-disciplinary
cancer team (p4) may initiate the process
to seek further opinions from other health
professionals, either due to low clinical evidence,
to resolve disagreements, justify/confirm their
recommendations, or share accountability. They may
decide to directly participate in the CMDM process or
wait for the consulted experts’ feedback and inform
the patient about the recommendations, along with
their own professional opinion.
• The insurance company, which is concerned with
the treatment costs, may demand further opinions
from its trusted health professionals before financially
approving any medical interventions. The insurance
agent (p6) may decide to represent the company
in the CMDM process and directly participate by
explicitly expressing their support/non-support of
each available treatment option or wait for the group’s
recommendations and then inform the patient whether
they can or cannot be covered by the insurance policy.
3.3. Key Requirements
This section describes a number of participant,
process and information-centric requirements that the
CMDM process has to satisfy to ensure that all
participants are fully supported.
3.3.1. Participant-Centric Requirements (ParRQs)
Fulfilling the following requirements may encourage
participation by the different types of stakeholders.
• Autonomy – Participants should have the opportunity
to exercise freedom of thought and free will and make
informed, unconditional, and uncoerced decisions
independent of other participants’ viewpoints. For
instance, the patient should have the freedom to
choose whether or not to reveal her spiritual or cultural
beliefs, and to whom.
• Transparency – Participants should have a clear
understanding of their right and obligations, and the
benefits and potential risks of participating in the
CMDM process. For instance, an external healthcare
professional might want clear communication about
the legal obligations of his/her participation and
negotiate them if needed. Participants should also
have the right to understand how their opinions and
views are collected, recorded, and stored, and when
and how this information is used and shared.
• Anonymity/Pseudonymity – Participants should have
the right to participate in the CMDM process and
express their true preferences and opinions without
fear or favour. Participants should also be able to
selectively reveal their identity to some or all of the
participants [26]. For instance, some fellow patients
might agree to participate only if they can use
pseudonyms and cannot be identified by the other
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participants as this might disclose very sensitive
information such as the fact that they had or still have
breast cancer and experienced the side effects of some
of the treatment options.
• Privacy – Participants should be able to control
how their personal information (including health
information, and personal preferences, opinions and
views) is shared with others. For instance, some
family members may want to grant the patient access
to their preferences for the different treatment options
but restrict access to other family members.
3.3.2. Process-Centric Requirements (ProRQs)
Participants may not contribute honestly to the
CMDM process if they do not consider it reliable and
trustworthy. Satisfying the following ProRQs may help
address this.
• Authenticity – The CMDM process should ensure
that only authenticated participants contribute to
decision-making and that the input data originates
from its purported source [27]. Knowing that the
authenticity of the participants is verified during
all stages of the CMDM process and providing
confirmation that the input data can be trusted will
give the patient confidence in the validity of outcomes.
• Accessibility – The CMDM process should allow
digital deliberation and collaboration among
geographically dispersed participants through verified
asynchronous communication and authorised sharing
of preferences, opinions, and ideas. For instance,
a patient located in Melbourne may want to invite
an oncologist and surgeon who are in Sydney and
Brisbane, respectively, to participate in the CMDM
process along with some fellow patients who are
potentially located in other countries.
• Automated Mediation – The CMDM process should
proceed with minimum or zero human moderation.
The participant who initiates the process should be
able to define some parameters such as the minimum
consensus (threshold) and maximum number of
iterations (rmax), but an automated consensus builder
should orchestrate the consensus reaching process
leading to an outcome. Knowing that the execution
of the process is delegated to a trusted mediator to
minimise (human) error and bias might increase the
participants’ engagement with the CMDM process.
• Reliability – Participants should have assurances
about the integrity of the CMDM process. The process
should be complete (i.e., cover all possible scenarios),
consistent (i.e., always return the same outcome for
a given process configuration and the same set of
inputs from all participants in each round of the
interaction), and accurate (i.e., return results that
are accurate as per the encoded consensus building
logic). For instance, if there is randomness in the
consensus building mechanism this will lead to the
participants questioning the quality of the outcomes
as running the process with the same decision matrices
might lead to different (better) decisions. Randomness
is not tolerated in systems that generate high-stakes
decisions and require non-repudiation of any kind.
3.3.3. Information-Centric Requirements (InfRQs)
Participants may abstain from contributing truthfully to
the CMDM process if they feel that their information
will not be kept private and secure. Satisfying the
following set of InfRQs may increase participants’ trust
in the process [28].
• Confidentiality – The CMDM process should
guarantee that participants’ personal information is
kept confidential at all times, i.e., it is only shared with
authorized entities based on the participants’ explicit
consent. For instance, doctor–patient confidentiality
is a legal privilege granted to patients [29].
• Integrity – The information collected during the
CMDM process should be maintained in a correct
state at all times. Nobody should be able to modify
the participants’ decision matrices, either accidentally
or maliciously. If a participant decides to leave the
CMDM process before consensus is reached or the
process has terminated, all of their data should be
treated as per prior agreement, i.e., it should be
destroyed or used anonymously but never modified to
bias or accelerate the consensus reaching process.
• Availability – Information should be made available
when requested by authorised entities. For instance,
when a participant wants to check their decision
matrix during a previous consensus round or when
the CMDM process needs to operate on individual
decision matrices at the end of each round to generate
the appropriate feedback to be sent to each participant.
• Auditability – At the end of the CMDM process, the
patient and/or lead clinician might want to conduct
a comprehensive examination of the process and
understand how the group achieved a decision without
violating the participants’ anonymity.
• Non-repudiation – The CMDM process should be
able to confirm the occurrence/non-occurrence of an
action. This is important to give assurance that the
sender of a decision matrix or (any information) is
provided with proof of delivery and the consensus
builder is provided with proof of the sender’s identity,
so neither can later deny the data exchange [27].
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• Trustworthiness – The CMDM process should
be able to verify identity and establish trust in
all participants. It should verify attributes of a
participant so that the patient has confidence in their
qualifications, capabilities, and ability to contribute to
the decision and fulfill assigned responsibilities.
• Privacy – The CMDM process needs to ensure that
privacy protections are implemented in the collection,
use, sharing, storage, transmittal, and disposal of
information that each participants should have control
over their personal information.
The ParRQs, ProcRQs, and InfRQs should be
collectively satisfied as they are complementary and will
not be effective if considered individually. For example,
if the CMDM process satisfies the ProcRQs and InfRQs
but not the ParRQs, this might result in abstention from
participation regardless of whether it is promoted as
reliable, trustworthy and information-secure. Therefore,
innovative mechanisms should be designed to ensure
that these requirements are satisfied to give all
participants confidence that the proposed CMDM
approach can replace the traditional SDM.
4. Proposed Platform
This section presents the high-level conceptual
architecture for the proposed platform and a prototype
implementation using the Ethereum2 blockchain. In
practice, the blockchain would be run by a consortium
of hospitals and insurance companies such that no one
single institution controls the network and participants
would be able to register with the platform using
appropriate mechanisms provided by the consortium.
4.1. Conceptual Architecture
Figure 2 depicts the high-level conceptual
architecture for the proposed CMDM platform. We
propose five stages for consensus building and discuss
them using the running example of an early breast
cancer patient p1 who has to choose between two
treatment options t1 and t2. We consider a scenario
where p1 does not directly participate in the CMDM
process, but instead makes a decision after reviewing
the recommendations from her partner p2, the lead
clinician p3, the multi-disciplinary cancer team p4,
fellow patients p5, and the insurance company p6. The
Consensus Builder is responsible for orchestrating the
CMDM process.
• Step 1. The platform sends invitations to participants






































































Figure 2. High-level architecture of the
patient-centred CMDM platform.
the terms and conditions of participation, and may
contain details about the patient (if not anonymous),
their medical condition, the invitee’s obligations as
a participant, details about other participants (if not
anonymous), liability (if any), etc. The invitation
should also provide an accessible link to the platform.
• Step 2. Participants accept or decline the invitation, or
ask for further information. As part of the invitation,
participants receive the predefined privacy and
confidentiality settings, either explicitly defined by
the patient, or automatically generated by the platform
using an appropriate access control mechanism. They
can modify the settings that apply to them at any
point during the process. Examples include identity
management to hide/reveal their real identity using
anonymisation/pseudo-anonymisation techniques,
and preference sharing rules to control who can access
their preferences (decision matrix). For the purpose
of illustration, we assume that all participants in our
scenario accept the invitation to join the process after
defining their privacy and confidentiality settings.
• Step 3. The patient defines the decision-making
parameters (i.e., treatment options, evaluation criteria,
consensus threshold, and maximum number of
consensus rounds) or asks for everyone’s involvement
to collectively identify them. The patient can decide
if she wants all participants to evaluate the same
treatment options using the same set of criteria, or
specify a different set for each participant based on
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their profiles and expected contribution. For instance,
the medical team can advise on the treatment options
according to c1: effectiveness, c2: side effects, c3:
survival rate, c4: invasiveness, and c5: recovery time,
whereas the insurance company can only advise on
c6: related costs. The patient can use the weighting
mechanism to assign importance weights to each
participant’s contribution subjectively, objectively or
using some combination of the two.
• Step 4. The patient triggers the Consensus Builder
once she is satisfied with the set of participants P
and their importance weights, and all participants
have defined their privacy and confidentiality settings
and agreed to the decision-making parameters. The
iterative consensus reaching process starts without any
further intervention from the patient by following the
steps depicted in Figure 1. A fixed deadline, defined
based on the criticality of the patient’s condition, may
be applied to each round to prevent delays and ensure
positive progression of the CMDM process.
• Step 5. An overall score is computed for the different
alternatives, t1 and t2 in our scenario, based on
the group’s last collective decision matrix. Using the
satisfaction measurement mechanism, participants are
then explicitly asked to indicate how satisfied they
are with the group’s final decision. These individual
scores, along with other relevant information such
as consensus degree, number of consensus rounds
needed to reach consensus (if applicable), and any
additional comments the participants want to share
with the patient, form part of the outcome sent
to the patient for consideration. The satisfaction
measurement is intended to increase the patient’s
confidence in the group decision.
4.2. Prototype Implementation
Figure 3 shows our proof-of-concept CMDM
platform implementation. The main CMDM process
is realised via two Smart Contracts – Consensus
Builder Contract and Access Control Contract. The
automated Consensus Builder, Weighting Mechanism,
and Satisfaction Measurement Mechanism are encoded
in the Consensus Builder Smart Contract. Similarly, the
Access Control Mechanism, which enables controlled
access to the information exchanged during the process
based on the participants’ preferences, is encoded in the
Access Control Smart Contract.
All interactions between the participants and the
platform happen via the API gateway. Participants
would need to first register themselves with the
platform. We omit the details on how this would occur
due to space limitations. Once they have registered,
participants can participate in one or more CMDM
Figure 3. Technical architecture of the
patient-centred CMDM platform.
process instances. In order to interact with the Smart
Contracts on the Ethereum Blockchain, all participants
need to have their own private keys that can be obtained
by registering with any Ethereum wallet provider.
Both Smart Contracts, written in Solidity3, are
deployed on the Ethereum blockchain. The Web3.py4
library is used to interact with the two Smart Contracts,
parse private keys into account addresses, and to
lodge transactions. We use Truffle5 as the development
framework and Ganache6, a local emulator of the
Ethereum Blockchain, for testing the prototype. We used
the keys provided by Ganache.
4.2.1. CMDM Orchestration Figure 4 illustrates
how the different participants interact with the two
Smart Contracts. We use the scenario described in
Section 4.1 to demonstrate how the prototype works and
the steps described below loosely correspond to the steps
outlined in Section 4.1.
• Step 1. The patient initiates the process and configures
the required parameters including questions related






Figure 4. Sequence diagram of participants’
interaction with Consensus and AccessControl.
and maximum number of consensus rounds. The
patient then adds the list of invited participants,
and configures the initial privacy settings. This is
illustrated in Figure 5.
• Step 2. Selected participants receive notification of
the invitation and can choose to accept or decline
the invitation. Participants that accept the invitation
are required to specify who can see their responses,
provided the patient has allowed participants to
selectively allow access to their responses when
configuring the process in the previous step. Once all
participants have accepted/declined their invitation,
the consensus reaching process can begin.
• Step 3. In each consensus round, participants retrieve
questions from the Smart Contract and respond to
them based on their personal preferences. This is
illustrated in Figure 6. Depending on how access
control has been configured, they may/may not
be allowed to view the individual responses/group
aggregated response in the previous round.
• Step 4. Once all participants have provided their
responses, the Consensus Builder aggregates the
results for the current round and calculates the
consensus degree. If the consensus degree exceeds the
threshold or the maximum number of rounds has been
reached, the process proceeds to Step 5, otherwise
Figure 5. Patient initiates a new process.
each participant is provided with a personalised
feedback that can help them align their responses with
the rest of the group in the next round and Steps 3 and
4 are repeated.
• Step 5. The patient and all participants receive the
group decision as illustrated in Figure 7. Note that the
returned result will be different for each participant
depending on how access control has been configured
for them.
• Step 6. As a final step, all participants provide an
indication of how satisfied they are with the group’s
decision and the process outcome is sent to the patient.
4.3. Discussion
Our proof-of-concept prototype implementation
has demonstrated the practicability of the proposed
patient-centered CMDM platform. Some of the
requirements identified in Section 3.3 are met by virtue
of the consensus reaching process design. The use
of a digital platform ensures that participants have
better accessibility. In the absence of face-to-face
interactions, participants may feel more empowered
and honest in sharing their personal preferences and
opinions. The consensus reaching process aims to
be transparent by design so that participants have a
clear understanding of their rights and obligations. It
supports iterative decision-making and fine-grained
access control over who can access each piece of
information. The use of automated mediation helps
increase trust in the process by minimising human error
and bias. The consensus reaching process balances
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Figure 6. Participant’s response to the questions.
Figure 7. Report showing part of the final result.
both medical (practitioners’ expertise) and supporting
perspectives (family members’ wishes and fellow
patients’ experiences) to ensure that patients (or their
representatives) can make a fully informed decision.
The ultimate goal of the CMDM process is to assist the
patient in figuring out which treatment option aligns
best with her personal preferences and values. Thus,
giving the patient (or their representatives) the option to
manually assign importance weights to each participant,
and hence decide the influence they should have during
the consensus reaching process (e.g., based on expertise
or social trust), guarantees that the process and the
outcome(s) are truly patient-centred. For instance, the
patient may give a bigger weight to the lead clinician,
multi-disciplinary cancer team, and fellow patients
to ensure that the final decision is backed by medical
expertise and real-life experience rather than being
driven by the family members’ wishes.
Using Smart Contracts to implement the consensus
reaching process further helps address additional
requirements identified in Section 3.3. Smart
Contracts are deterministic and immutable computer
programs that are stored, executed and verified on the
Blockchain. Once deployed, a Smart Contract’s
code cannot be changed, even by the authors
themselves. Encoding the consensus reaching business
logic on the Smart Contract guarantees the integrity of
the process. Similarly, all interactions (and associated
information) between the consensus builder and
the participants occur through the Consensus Smart
Contract and get recorded on the Blockchain. Recording
interactions on the Blockchain ensures integrity of the
information as well as traceability, auditability and
non-repudiability, in turn ensuring accountability in
the decision-making process. The use of Blockchain
also enables regulatory oversight or evidence for legal
remedies in the case of negligence or undesirable
outcomes resulting from the medical intervention. The
use of pseudonyms enables participants to keep their
identity hidden in the CMDM process with some level
of anonymity while allowing the determination of
identity if required. Implementing the access control
mechanism using Smart Contract ensures that only
authorised participants have access to the interaction
data based on the allowed permissions.
However, additional support is required for ensuring
full privacy and confidentiality of the data that is written
on the blockchain. One way to do this is by encrypting
the data before it is written on the blockchain using
symmetric or assymetric encryption. An alternative way
is to store the data and decisions exchanged during
the CMDM process off-chain in an encrypted database
and include a hash of the data on the Blockchain.
This requires reconsideration of the consensus builder
implementation architecture.
5. Conclusion
Truly patient-centered care should not be a one-off
dyadic encounter between the patient and physician,
but it should also involve other stakeholders including
family members, carers, and fellow patients. In this
paper, we proposed a novel platform for collaborative
medical decision-making (CMDM) that relies on a
patient-centred consensus reaching process, and allows
patients to initiate a collaboration that extends beyond
the traditional shared decision-making model to include
both medical and non-medical perspectives in selecting
an appropriate treatment option. Our solution leverages
Blockchain-based Smart Contracts to address some of
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the key requirements of CMDM including ensuring
accessibility, accountability, confidentiality, privacy,
and transparency. We implemented a proof-of-concept
prototype using the private Ethereum Blockchain
to demonstrate practicability from a technical
perspective. As future work, we plan to conduct studies
with actual stakeholders to evaluate acceptability of
the proposed solution, and also look at implementation
strategies to ensure enhanced data protection.
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